EZH2 inhibitors (Aurigene)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameEZH2 inhibitors (Aurigene)
Drug Alias Nameenhancer of zeste homolog 2 (Aurigene)EZH2 modulators (Aurigene)AU-2121
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 degraders
TargetsHistone-lysine N-methyltransferase EZH2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAurigene Oncology Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAurigene Oncology Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A